XTX Topco’s GSK GSK Stock Holding History

XTX Topco’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54,270	Closed	-$2.66M	–	4030
2025 Q4	$2.66M	Sell	54,270 -10,613	-16%	-$495K	0.07%	397
2025 Q3	$2.8M	Buy	64,883 +13,604	+27%	+$531K	0.15%	126
2025 Q2	$1.97M	Buy	+51,279	New	+$1.96M	0.08%	342
2025 Q1	–	Sell	-7,140	Closed	-$241K	–	2656
2024 Q4	$241K	Sell	7,140 -41,185	-85%	-$1.48M	0.02%	1401
2024 Q3	$1.98M	Buy	48,325 +19,721	+69%	+$807K	0.14%	149
2024 Q2	$1.1M	Buy	+28,604	New	+$1.2M	0.09%	323
2024 Q1	–	Sell	-22,692	Closed	-$841K	–	2026
2023 Q4	$841K	Buy	22,692 +17,111	+307%	+$614K	0.18%	55
2023 Q3	$202K	Sell	5,581 -2,610	-32%	-$92.6K	0.03%	1012
2023 Q2	$292K	Buy	+8,191	New	+$294K	0.05%	747
2022 Q3	–	Sell	-25,489	Closed	-$1.39M	–	1209
2022 Q2	$1.39M	Buy	+25,489	New	+$1.41M	0.57%	11
2021 Q4	–	Sell	-4,683	Closed	-$224K	–	811
2021 Q3	$224K	Buy	+4,683	New	+$235K	0.08%	455

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

XTX Topco's GSK Position: Q1 2026 in Review

XTX Topco sold out of GSK (GSK) in Q1 2026, closing a stake of 54,270 shares — an estimated $2.66M sold.

XTX Topco first reported a position in GSK in Q3 2021 and held it in 11 quarters. The position peaked at $2.8M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

XTX Topco reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
XTX Topco sold 54,270 GSK shares in Q1 2026, an estimated $2.66M.
XTX Topco first reported a position in GSK in Q3 2021 and held it in 11 quarters.
XTX Topco's GSK position peaked at $2.8M in Q3 2025.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.